Low insulin, IGF-I and IGFBP-3 levels in children with Prader-Labhart-Willi syndrome

被引:73
作者
Eiholzer, U
Stutz, K
Weinmann, C
Torresani, T
Molinari, L
Prader, A
机构
[1] Ctr Adolescent Med, CH-8006 Zurich, Switzerland
[2] Fdn Growth Puberty Adolescence, CH-8006 Zurich, Switzerland
[3] Univ Zurich, Dept Paediat, CH-8032 Zurich, Switzerland
关键词
growth hormone deficiency; Prader-Willi syndrome;
D O I
10.1007/s004310050961
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
It: is well established that insulin-like growth factor I (ICF-I), insulin-like growth factor binding protein-3 (IGFBP-3) and insulin are low in growth hormone deficiency, but due to their dependence on nutrition, they are elevated in healthy obese children. As the presence of growth hormone deficiency in Prader-Labhart-Willi syndrome (PWS) is still controversial, we studied insulin, ICF-I and IGFBP-3 levels in 19 children with PWS (age range 0.5-14.6 years). Serum concentrations of insulin (SDS: -0.7 +/- 0.9, P = 0.01) and IGF-I (SDS: -0.7 +/- 0.8,P = 0.002) were low, but IGFBP-3 (SDS: -0.3 +/- 1.2, P = 0.2) was normal compared to normal weight age-matched children. Since children with PWS are typically obese, insulin, IGF-I and IGFBP-3 levels should be compared to normal obese children who present increased levels of these hormones. In comparison to data of healthy obese children reported in the literature, not only IGF-I, but also IGFBP-3 levels are low and fasting insulin levels even very low, suggesting a growth hormone deficiency.
引用
收藏
页码:890 / 893
页数:4
相关论文
共 38 条
  • [1] Angulo M, 1996, J PEDIATR ENDOCR MET, V9, P393
  • [2] ANGULO M, 1991, Journal of Pediatric Endocrinology, V4, P167
  • [3] A SPECIFIC RADIOIMMUNOASSAY FOR THE GROWTH-HORMONE (GH)-DEPENDENT SOMATOMEDIN-BINDING PROTEIN - ITS USE FOR DIAGNOSIS OF GH DEFICIENCY
    BLUM, WF
    RANKE, MB
    KIETZMANN, K
    GAUGGEL, E
    ZEISEL, HJ
    BIERICH, JR
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1990, 70 (05) : 1292 - 1298
  • [4] THE PRADER-WILLI SYNDROME - A STUDY OF 40 PATIENTS AND A REVIEW OF THE LITERATURE
    BRAY, GA
    DAHMS, WT
    SWERDLOFF, RS
    FISER, RH
    ATKINSON, RL
    CARREL, RE
    [J]. MEDICINE, 1983, 62 (02) : 59 - 80
  • [5] BRAY GA, 1990, FRONT NEUROENDOCRIN, V11, P128
  • [6] BRAY GA, 1992, PROG BRAIN RES, V93, P333
  • [7] PREVALENCE STUDY OF PRADER-WILLI SYNDROME IN NORTH-DAKOTA
    BURD, L
    VESELY, B
    MARTSOLF, J
    KERBESHIAN, J
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS, 1990, 37 (01): : 97 - 99
  • [8] BUTLER MG, 1991, PEDIATRICS, V88, P853
  • [9] GROWTH-HORMONE (GH) RESPONSE TO COMBINED PYRIDOSTIGMINE AND GH-RELEASING HORMONE ADMINISTRATION IN PATIENTS WITH PRADER-LABHARD-WILLI SYNDROME
    CAPPA, M
    GROSSI, A
    BORRELLI, P
    GHIGO, E
    BELLONE, J
    BENEDETTI, S
    CARTA, D
    LOCHE, S
    [J]. HORMONE RESEARCH, 1993, 39 (1-2) : 51 - 55
  • [10] CASSIDY SB, 1987, AM J MED GENET, V28, P922